Research Article

Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

Table 4

Secondary outcomes. Values are presented as n (%) or mean ± standard deviation.

VariableGroup
PENG (n = 25)Control (n = 25)

Time to first opioid demand
 0–3 h postoperatively0 (0.0)6 (24.0)<0.0011
 3–6 h postoperatively0 (0.0)8 (32.0)
 6–9 h postoperatively3 (12.0)10 (40.0)
 9–12 h postoperatively5 (20.0)1 (4.0)
 >12 h postoperatively17 (68.0)0 (0.0)
Quadriceps muscle strength
 Before block
  0 = intact20 (80.0)15 (60.0)0.1131
  1 = reduced5 (20.0)6 (24.0)
  2 = absent0 (0.0)4 (16.0)
  3 = uncheckable
 At 6 h postoperatively
  0 = intact16 (64.0)14 (56.0)0.2621
  1 = reduced7 (28.0)6 (24.0)
  2 = absent2 (8.0)1 (4.0)
  3 = uncheckable0 (0.0)4 (16.0)
 At 12 h postoperatively
  0 = intact18 (72.0)15 (60.0)0.1801
  1 = reduced7 (28.0)6 (24.0)
  2 = absent0 (0.0)4 (16.0)
  3 = uncheckable
 At 24 h postoperatively
  0 = intact20 (80.0)15 (60.0)0.1131
  1 = reduced5 (20.0)6 (24.0)
  2 = absent0 (0.0)4 (16.0)
  3 = uncheckable
Postoperative complications
 Delirium0 (0.0)2 (8.0)0.4901
 Respiratory depression (hypoxia, hypopnea)0 (0.0)0 (0.0)
 Hypotension0 (0.0)1 (4.0)1.0001
 Nausea1 (4.0)1 (4.0)1.0001
 Vomiting1 (4.0)1 (4.0)1.0001
 Headache1 (4.0)2 (8.0)1.0001
 Dizziness1 (4.0)4 (16.0)0.3491
Patient satisfaction
 Satisfied22 (88.0)13 (52.0)0.0052
 Unsatisfied3 (12.0)12 (48.0)

1 values were derived from Fisher’s exact test. 2 values were derived using the chi-squared test. PENG, pericapsular nerve group; control, control group.